CCR1-REZEPTOR-ANTAGONISTEN ZUR BEHANDLUNG U.A. DEMYELINISIERENDER ENTZÜNDLICHER ERKRANKUNGEN
摘要
<p>The invention provides compounds having the formula (I): wherein R 1 is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.</p>
